Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danqi Chen

Showing results (71-80 of 105) with videos related to

Pageof 11
Sort By:
Neuroscience Letters|September 5, 2018
TLR4 signaling pathway mediates the LPS/ischemia-induced expression of monocytechemotactic protein-induced protein 1 in microgliaShumin Chen, Chenfei Lyu, Junming Zhou, et al.
European Journal of Medicinal Chemistry|February 8, 2023
2,6-diazaspiro[3.4]octan-7-one derivatives as potent sigma-1 receptor antagonists that enhanced the antinociceptive effect of morphine and rescued morphine toleranceKequan Fu, Wen Xu, Ruicong Yang, et al.
Frontiers in Plant Science|February 19, 2025
Optimizing the thermostability of triketone dioxygenase for engineering tolerance to mesotrione herbicide in soybean and cottonStephen M G Duff, Lei Shi, Danqi Chen, et al.
Bioorganic & Medicinal Chemistry|May 3, 2017
Design and optimization of purine derivatives as in vivo active PDE10A inhibitorsLiu Chen, Danqi Chen, Le Tang, et al.
Bioorganic & Medicinal Chemistry Letters|August 17, 2016
Design and synthesis of benzylpiperidine inhibitors targeting the menin-MLL1 interfaceJing Ren, Wei Xu, Le Tang, et al.
The Journal of Biological Chemistry|October 1, 2014
Arsenic induces polyadenylation of canonical histone mRNA by down-regulating stem-loop-binding protein gene expressionJason Brocato, Lei Fang, Yana Chervona, et al.
Journal of Medicinal Chemistry|January 23, 2025
Structure-Based Rational Design and Evaluation of BET-Aurora Kinase Dual-Inhibitors for Treatment of CancersKaikai Lyu, Ying Ren, Jie Mou, et al.
Journal of Medicinal Chemistry|February 13, 2025
Design of Selective BRD4 Inhibitors for the Treatment of Autosomal Dominant Polycystic Kidney DiseaseYueyue Yang, Hongli Liu, Haoxing Yuan, et al.
European Journal of Medicinal Chemistry|June 23, 2026
Structure-guided discovery of 1H-pyrazolo[3,4-c]pyridin-3-amines as a novel class of hematopoietic progenitor kinase 1 (HPK1) inhibitorsHuanyu Shi, Haotian Tang, Yan Li, et al.
Medcomm|July 11, 2024
Remodeling tumor-associated macrophage for anti-cancer effects by rational design of irreversible inhibition of mitogen-activated protein kinase-activated protein kinase 2Danyi Wang, Deqiao Sun, Xiaoyan Wang, et al.
Pageof 11

Showing results (71-80 of 105) with videos related to

Sort By:
Pageof 11
Neuroscience Letters|September 5, 2018
TLR4 signaling pathway mediates the LPS/ischemia-induced expression of monocytechemotactic protein-induced protein 1 in microgliaShumin Chen, Chenfei Lyu, Junming Zhou, et al.
European Journal of Medicinal Chemistry|February 8, 2023
2,6-diazaspiro[3.4]octan-7-one derivatives as potent sigma-1 receptor antagonists that enhanced the antinociceptive effect of morphine and rescued morphine toleranceKequan Fu, Wen Xu, Ruicong Yang, et al.
Frontiers in Plant Science|February 19, 2025
Optimizing the thermostability of triketone dioxygenase for engineering tolerance to mesotrione herbicide in soybean and cottonStephen M G Duff, Lei Shi, Danqi Chen, et al.
Bioorganic & Medicinal Chemistry|May 3, 2017
Design and optimization of purine derivatives as in vivo active PDE10A inhibitorsLiu Chen, Danqi Chen, Le Tang, et al.
Bioorganic & Medicinal Chemistry Letters|August 17, 2016
Design and synthesis of benzylpiperidine inhibitors targeting the menin-MLL1 interfaceJing Ren, Wei Xu, Le Tang, et al.
The Journal of Biological Chemistry|October 1, 2014
Arsenic induces polyadenylation of canonical histone mRNA by down-regulating stem-loop-binding protein gene expressionJason Brocato, Lei Fang, Yana Chervona, et al.
Journal of Medicinal Chemistry|January 23, 2025
Structure-Based Rational Design and Evaluation of BET-Aurora Kinase Dual-Inhibitors for Treatment of CancersKaikai Lyu, Ying Ren, Jie Mou, et al.
Journal of Medicinal Chemistry|February 13, 2025
Design of Selective BRD4 Inhibitors for the Treatment of Autosomal Dominant Polycystic Kidney DiseaseYueyue Yang, Hongli Liu, Haoxing Yuan, et al.
European Journal of Medicinal Chemistry|June 23, 2026
Structure-guided discovery of 1H-pyrazolo[3,4-c]pyridin-3-amines as a novel class of hematopoietic progenitor kinase 1 (HPK1) inhibitorsHuanyu Shi, Haotian Tang, Yan Li, et al.
Medcomm|July 11, 2024
Remodeling tumor-associated macrophage for anti-cancer effects by rational design of irreversible inhibition of mitogen-activated protein kinase-activated protein kinase 2Danyi Wang, Deqiao Sun, Xiaoyan Wang, et al.
Pageof 11